These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28049080)

  • 1. Metabolic syndrome or glucose challenge in first episode of psychosis?
    Garcia-Rizo C; Fernandez-Egea E; Oliveira C; Meseguer A; Cabrera B; Mezquida G; Bioque M; Penades R; Parellada E; Bernardo M; Kirkpatrick B
    Eur Psychiatry; 2017 Mar; 41():42-46. PubMed ID: 28049080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic risk factors in drug-naive patients with first-episode psychosis.
    Verma SK; Subramaniam M; Liew A; Poon LY
    J Clin Psychiatry; 2009 Jul; 70(7):997-1000. PubMed ID: 19497246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
    Jensen KG; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JRM; Fink-Jensen A; Pagsberg AK
    J Clin Psychiatry; 2017; 78(8):e1035-e1046. PubMed ID: 28102978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway.
    Garcia-Rizo C; Kirkpatrick B; Fernandez-Egea E; Oliveira C; Bernardo M
    Psychoneuroendocrinology; 2016 May; 67():70-5. PubMed ID: 26878465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort.
    Garrido-Torres N; Ruiz-Veguilla M; Alameda L; Canal-Rivero M; Ruiz MJ; Gómez-Revuelta M; Ayesa-Arriola R; Rubio-García A; Crespo-Facorro B; Vázquez-Bourgon J
    Schizophr Res; 2022 Aug; 246():277-285. PubMed ID: 35878542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of cardiovascular co-morbidities in young patients with early onset psychosis: State of the art and therapeutic perspectives].
    Frajerman A; Morin V; Chaumette B; Kebir O; Krebs MO
    Encephale; 2020 Oct; 46(5):390-398. PubMed ID: 32571543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.
    Fernandez-Egea E; Bernardo M; Donner T; Conget I; Parellada E; Justicia A; Esmatjes E; Garcia-Rizo C; Kirkpatrick B
    Br J Psychiatry; 2009 May; 194(5):434-8. PubMed ID: 19407273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
    Sengupta S; Parrilla-Escobar MA; Klink R; Fathalli F; Ying Kin Ng ; Stip E; Baptista T; Malla A; Joober R
    Schizophr Res; 2008 Jul; 102(1-3):329-36. PubMed ID: 18396386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods.
    van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    J Clin Psychiatry; 2006 Oct; 67(10):1493-500. PubMed ID: 17107239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
    Vázquez-Bourgon J; Pérez-Iglesias R; Ortiz-García de la Foz V; Suárez Pinilla P; Díaz Martínez Á; Crespo-Facorro B
    Psychopharmacology (Berl); 2018 Jan; 235(1):245-255. PubMed ID: 29075885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis.
    Suvitaival T; Mantere O; Kieseppä T; Mattila I; Pöhö P; Hyötyläinen T; Suvisaari J; Orešič M
    Transl Psychiatry; 2016 Nov; 6(11):e951. PubMed ID: 27845774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in antipsychotic-naïve patients with first-episode psychosis: a systematic review and meta-analysis.
    Garrido-Torres N; Rocha-Gonzalez I; Alameda L; Rodriguez-Gangoso A; Vilches A; Canal-Rivero M; Crespo-Facorro B; Ruiz-Veguilla M
    Psychol Med; 2021 Oct; 51(14):2307-2320. PubMed ID: 34493353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis.
    Fernandez-Egea E; Bernardo M; Heaphy CM; Griffith JK; Parellada E; Esmatjes E; Conget I; Nguyen L; George V; Stöppler H; Kirkpatrick B
    Schizophr Bull; 2009 Mar; 35(2):437-42. PubMed ID: 19279086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood cell count in antipsychotic-naive patients with non-affective psychosis.
    Garcia-Rizo C; Casanovas M; Fernandez-Egea E; Oliveira C; Meseguer A; Cabrera B; Mezquida G; Bioque M; Kirkpatrick B; Bernardo M
    Early Interv Psychiatry; 2019 Feb; 13(1):95-100. PubMed ID: 28786532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of early life events on glucose levels in first-episode psychosis.
    Garcia-Rizo C; Cabrera B; Bioque M; Mezquida G; Lobo A; Gonzalez-Pinto A; Diaz-Caneja CM; Corripio I; Vieta E; Baeza I; Garcia-Portilla MP; Gutierrez-Fraile M; Rodriguez-Jimenez R; Garriga M; Fernandez-Egea E; Bernardo M;
    Front Endocrinol (Lausanne); 2022; 13():983792. PubMed ID: 36545332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis.
    Perry BI; McIntosh G; Weich S; Singh S; Rees K
    Lancet Psychiatry; 2016 Nov; 3(11):1049-1058. PubMed ID: 27720402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.